RxDoctor Payments Data

Kathleen Sisk, NP

Psychiatric/Mental Health · Hillsborough, NCNPI 1932457694

Payments from drug & device makers

$1,100in general payments, 2019–2025

Across 44 payments — averaging $25.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$273
  • Supernus Pharmaceuticals, Inc.$167
  • Johnson & Johnson$125
  • AbbVie$115
  • Alkermes, Inc.$113
  • Takeda Pharmaceuticals U.S.A., Inc.$109
  • plus $198 from 4 others

What the payments were for

  • Food & beverage$98990%
  • Education$11110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,100 in reported general payments places this provider in the 65th percentile of 947 psychiatric/mental health providers in North Carolina.

See all psychiatric/mental health providers in North Carolina

Medicare billing

Part B allowed, 2024
$34,042
Medicare patients
116
Services billed
332

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine21$182,664
VraylarCariprazine Hcl51$77,689
RexultiBrexpiprazole44$66,848
AristadaAripiprazole Lauroxil11$34,656
Lurasidone Hcl85$22,629
TrintellixVortioxetine Hydrobromide39$22,238
BelsomraSuvorexant18$7,292
Aripiprazole171$7,151
VyvanseLisdexamfetamine Dimesylate16$6,368
Clonazepam555$5,307
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine60$4,303
Duloxetine Hcl270$4,166
Quetiapine Fumarate218$4,062
Clozapine47$4,014
Bupropion XlBupropion Hcl139$3,695

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$273$182,66421 claims
AbbVieVraylar$115$77,68951 claims
Otsuka America Pharmaceutical, Inc.Rexulti$36$66,84844 claims
Alkermes, Inc.Aristada$113$34,65611 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$109$28,60655 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 947 psychiatric/mental health providers in North Carolina.

Other psychiatric/mental health in Hillsborough

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →